Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemia
jRCT2080222949Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of S-237648 in obesity, Abdominal adiposity (ABCD), prediabetes and 3 more, sponsored by Shionogi & Co., Ltd.
02
Drugs
S-237648
03
Conditions
obesityAbdominal adiposity (ABCD)prediabetestype 2 diabetes mellitus (T2DM)hyperlipidemia
Beyond the preview
Go deeper on jRCT2080222949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222949.